The age association remained significant after additional adjustments for clinical and social factors such as loneliness and pain. As such, age-specific factors cannot alone explain the poorer MDD course associated with older age.
Investigators sought to determine the frequency of major depressive disorder in patients in epilepsy clinics.
This association suggests that it may be beneficial for practitioners to have increased awareness of depression as a possible adverse effect of medications.
An estimated 37.2% of people in the United States use medications that have an adverse effect of depression.
Negative experiences on social media are more impactful than positive interactions as it relates to depressive symptoms in young adults.
Preliminary generalizations point toward the potential therapeutic efficacy of targeting loneliness and social support for patients.
The notion that abortion harms women's mental health may be misinformed and should be re-examined according to scientific data such as these.
This study was prompted by an ongoing shortage of injectable caffeine sodium benzoate in the United States from 2011 to 2017.
These analyses may serve clinicians in addressing potential psychiatric obstacles in patients undergoing fertility treatments.
These data may be helpful in developing targeted interventions for women at risk for postpartum depression.
As this and previous research on dose increase strategies have produced inconsistent findings, the researchers recommended clinicians consider other responses to antidepressant treatment failure, at least for selective serotonin reuptake inhibitors.
These data could be useful to clinicians and patients alike in selecting the proper treatment method.
The Janssen Pharmaceutical Companies of Johnson & Johnson have announced the results of 2 long-term phase 3 clinical trials examining esketamine nasal spray in patients with treatment-resistant depression.
Among men, those with active major depression were less likely to have a partner achieve conception.
Examining the Relationship Between Childhood Anxiety, Depression and Risk for Cardiovascular DiseaseMay 31, 2018
The potential plasticity of the cardiovascular system during childhood may explain the lack of significant relationship between depression and anxiety symptomatology and CVD risk in this study population.
Routine assessments of these markers should be conducted before and during treatment as they may inform prognoses.
Experts provide practical tips to aid in the often-challenging process of incorporating pharmacogenetic testing into clinical practice.
The relationship between pain and cognitive dysfunction was explained by sleep disturbance and depressive symptoms.
Carbamazepine, in particular, was associated with lower hazards for depression and anxiety in secondary analyses.
Active major depression in the male partner may lower the likelihood of pregnancy.
Rheuatology Advisor speaks with a psychologist about addressing mental health in patients with inflammatory arthritis.
The erythematotelangiectatic, papulopustular, phymatous, and ocular forms of rosacea can lead to psychological distress.
A substantial proportion of these individuals diagnosed with HIV, psychiatric disorders, and substance use disorders are out of care and urgently require intervention.
These findings suggest a strong association between greater depressive symptoms and markers of brain aging as well as impaired episodic memory.
Widespread use of antidepressants may be contributing to long-term increased risk for weight gain.
When assessing risk for postpartum episodes, clinicians should inquire about family history of psychiatric disorders broadly and not limit discussion to postpartum psychiatric disorders or psychiatric disorders in female relatives.
Sedentary behavior is closely linked to a more articulated pattern of psychological variables, largely influenced by sex-related differences in the individual psychological characteristics.
Baseline depressive symptoms were associated with pain and disability in adolescents with juvenile idiopathic arthritis.
Gender may not influence vulnerability for developing new-onset depression during interferon-alpha therapy.
A placebo-controlled study could further clarify these results and possibly strengthen the case for antidepressant treatment for depression in vascular cognitive impairment.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Should Physicians Treat Family and Friends? Three Experts Weigh In
- Transference in the Age of #MeToo: What Counts as Harassment From a Patient?
- Dialectical Behavior Therapy Effective in Reducing Suicide Attempts, Self-Harm in Adolescents
- Influence of Psychostimulants on BMI and Height in Youth With ADHD
- Medication Adherence Predictors in Patients With Severe Psychiatric Disorders
- Court-Mandated Substance Abuse Treatment: Exploring the Ethics and Efficacy
- ADHD Treatments
- Esketamine Nasal Spray: A New Treatment Possibility for Treatment-Resistant Depression
- Pharmacogenetics in Psychiatry: Promising Developments and Potential Pitfalls
- Substance Abuse and Primary Psychosis: A Closer Look
- Functional Restoration for Chronic Pain and Depression in the Elderly: Pharmacotherapy and Beyond
- Efficacy of Long-Acting Injectable Antipsychotics vs Oral Antipsychotics
- Older Age Associated With Worse Major Depressive Disorder Outcomes
- Preoperative Psychiatric Diagnoses Not Associated With Bariatric Surgery Outcomes
- Medical Clearance of Psych Patients in the ED: Consensus Recommendations